Prulifloxacin

Basic Information

Item Value
DrugBank ID DB11892
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 97

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 heart disease KG + DL
2 Laubry-Pezzi syndrome KG + DL
3 Pierre Robin syndrome associated with a chromosomal anomaly KG + DL
4 genetic syndromic Pierre Robin syndrome KG + DL
5 partial deletion of the long arm of chromosome 7 KG + DL
6 orofacial clefting syndrome KG + DL
7 pulmonary valve disease KG + DL
8 disorder of fucoglycosan synthesis KG + DL
9 mitral valve disease KG + DL
10 Jeune syndrome situs inversus KG + DL
11 partial deletion of the long arm of chromosome 22 KG + DL
12 interventricular septum aneurysm KG + DL
13 heart conduction disease KG + DL
14 heart neoplasm KG + DL
15 heart valve disease KG + DL
16 congenital anomaly of ventricular septum KG + DL
17 cardiovascular disease KG + DL
18 pericardium disease KG + DL
19 myocardial rupture KG + DL
20 carcinoid heart disease KG + DL
21 cardiac anomalies-heterotaxy syndrome KG + DL
22 cor biloculare KG + DL
23 heart aneurysm KG + DL
24 patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome KG + DL
25 microcephaly-cardiac defect-lung malsegmentation syndrome KG + DL
26 white forelock with malformations KG + DL
27 aortopulmonary window KG + DL
28 cardiac ventricle disease KG + DL
29 myocardial disorder KG + DL
30 neoplasm of pericardium KG + DL
31 tarp syndrome KG + DL
32 brain malformation-congenital heart disease-postaxial polydactyly syndrome KG + DL
33 autoimmune atherosclerosis KG + DL
34 8q24.3 microdeletion syndrome KG + DL
35 Bosley-Salih-Alorainy syndrome KG + DL
36 cardiac disease with cataract KG + DL
37 cardiovascular organ benign neoplasm KG + DL
38 bronchitis KG + DL
39 PHACE syndrome KG + DL
40 high output heart failure KG + DL
41 defect in conserved oligomeric Golgi complex KG + DL
42 polyvalvular heart disease syndrome KG + DL
43 symptomatic heart failure KG + DL
44 autoimmune vasculitis KG + DL
45 malformation syndrome with short stature KG + DL
46 cardiovascular cancer KG + DL
47 genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability KG + DL
48 atrioventricular defect-blepharophimosis-radial and anal defect syndrome KG + DL
49 postoperative ventricular dysfunction KG + DL
50 laryngotracheitis KG + DL

(Showing top 50 of 97 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.